Patent application number | Description | Published |
20130018703 | METHOD AND SYSTEM FOR DISTRIBUTED AND COLLABORATIVE MONITORINGAANM Majeed; BasimAACI Abu DhabiAACO AEAAGP Majeed; Basim Abu Dhabi AEAANM Du; XiaofengAACI IpswichAACO GBAAGP Du; Xiaofeng Ipswich GBAANM Bordbar; BehzadAACI BirminghamAACO GBAAGP Bordbar; Behzad Birmingham GB - A system is provided for monitoring the performance of a service within a business process environment is provided, the system including, locally to said service and preferably for each service: an information collector collecting information about the performance of said service in real-time; a database storing information about the performance of said service over time; and a control unit processing the information collected by said information collector and determining information to be stored in said database. A method of distributed monitoring of the performance of services within a business process environment is also provided. Further aspects provide a system and method for assisting in the design of a business process which determines whether services intended to be included in that process meet a performance criterion and a system and method for monitoring the performance of a plurality of services in a business process environment which determines whether a service which is intended to be used in a business process meets a performance criterion. | 01-17-2013 |
20130262443 | METHOD AND SYSTEM FOR PROCESSING DATA QUERIES - The invention relates to a method and system that provide a high performance and extremely scalable triple store within the Resource Description Framework (or alternative data models), with optimized query execution. An embodiment of the invention provides a data storage and analysis system to support scalable monitoring and analysis of business processes along multiple configurable perspectives and levels of granularity. This embodiment analyses data from processes that have been already executed and from ongoing processes, as a continuous flow of information. This embodiment provides defining and monitoring processes based on no initial domain knowledge about the process and such that the process will be built only from the incoming flow of information. Another embodiment of the invention provides a grid infrastructure that allows storage of data across many grid nodes and distribution of the workload, avoiding the bottleneck represented by constantly querying a database. | 10-03-2013 |
20130262502 | METHOD AND SYSTEM FOR CONTINUOUS QUERY PROCESSING - The invention relates to a method and system that provide a continuous querying mechanism that analyses real-time data streams to generate relevant results. It leverages data grid and event processing technology to provide a high performance and extremely scalable continuous querying solution. An embodiment of the invention provides a flexible querying language and data storage to allow users to register their interest in specific types of data, e.g. processes. The users are notified of matching results using an event-based mechanism. In order to efficiently analyse a large amount of data, the embodiment uses a grid infrastructure that allows storage of the data across many grid nodes and distributes the query execution workload, avoiding the bottleneck represented by constantly querying a database. Continuous queries are stored in a Continuous Query Registry and that Registry is invoked every time an insert or update event occurs on the triple store. | 10-03-2013 |
Patent application number | Description | Published |
20120190744 | Preservative System for Cosmetic Formulations- Compositions and Methods Thereof - The present invention relates to preservation of cosmetic formulations. More specifically, the present invention relates to a preservative composition for cosmetic formulations comprising thymol, monolaurin and magnolol obtained from supercritical fluid extracts of | 07-26-2012 |
20130012579 | Anti-obesity Potential of Calebin A - The present invention discloses the potential of Calebin A in inhibiting adipogenesis and applications thereof in obesity management. The present invention elucidates the potential of Calebin A to favorably modulate biochemical markers associated with obesity. Notable biomodulatory properties of Calebin A include inhibiting leptin production, increasing adiponectin expression and inhibiting local (adipocyte) and systemic inflammation caused by pro-inflammatory cytokines Tumor Necrosis Factor (TNF-α), Interleukin-6 (IL-6) and Interleukin-1 (IL-1β). | 01-10-2013 |
20130136772 | REGULATION OF IMMUNE RESPONSE BY COLOCYNTHIN AND/OR ITS DERIVATIVES - The present invention relates to a method of inhibiting pro-inflammatory and T-cell mediated cytokines, said method comprising step of administering to a subject in need thereof a therapeutically effective amount of colocynthin and/or its derivatives. The invention also relates to a method of inhibiting T-cell surface markers and to a method of regulating immune response by colocynthin and/or its derivatives. | 05-30-2013 |
20130217782 | Orally bioavailable stilbenoids-Compositions and therapeutic applications thereof - Disclosed is a novel sirtuin modulating composition comprising an orally bioavailable SIRT-1 enhancing compound 3,5-dimethoxy-3,4′-dihydroxystilbene represented by STR#I. Also disclosed is an anti-acne composition comprising 3,5-dimethoxy-3,4′-dihydroxystilbenes represented by STR#I. Further, a novel sirtuin modulating composition comprising an orally bioavailable SIRT-1 enhancing compound 2,3′,5′,6-tetrahydroxy-trans-stilbene represented by STR#II is also disclosed. | 08-22-2013 |
20130245075 | MELANOGENESIS INHIBITION-METHODS AND COMPOSITIONS THEREOF - The present invention relates to melanogenesis inhibition using an effective amount of piper longumine obtained from the roots of | 09-19-2013 |
20130281544 | HEPATOPROTECTANT ACTIVITY OF GARCINOL - The present invention discloses the hepatoprotective potential of garcinol. | 10-24-2013 |
20130295668 | Synergistic Selenopeptide Formulations For The Protection of Dermal Papilla Cells - The present invention discloses selenium peptide based synergistic compositions for the protection (morphology and viable numbers) of dermal papilla cells. The synergistic compositions disclosed in the present invention comprise (a) 1-O-galloyl-β-D-glucose (β-glucogallin) or 1-O-galloyl-β-D-glucose (β-glucogallin) and gallates (b) concentrate of liquid endosperm of | 11-07-2013 |
20140024706 | COMPOSITION COMPRISING SCIRPUSIN A AND SCIRPUSIN B AND ANTI-ADIPOGENESIS/ANTI-OBESITY POTENTIAL THEREOF - Disclosed is a composition comprising scirpusin A and scirpusin B and anti-obesity potential thereof. Also disclosed are methods of inhibiting adipogenesis using a composition comprising scirpusin A and scirpusin B. The present invention also disclosed methods of therapeutically managing obesity in mammals using a composition comprising scirpusin A and scirpusin B. Still further, the present invention also relates to a method of obtaining compositions comprising A. scirpusin A and scirpusin B and B. piceatannol and its dimers scirpusin A and scirpusin B through bioactivity guided fractionation of the rhizomes of | 01-23-2014 |
20140094517 | PRESERVATIVE SYSTEM FOR COSMETIC FORMULATIONS- COMPOSITIONS AND METHODS THEREOF - The present invention relates to preservation of cosmetic formulations. More specifically, the present invention relates to a preservative composition for cosmetic formulations comprising thymol, monolaurin and magnolol obtained from supercritical fluid extracts of | 04-03-2014 |
20140206842 | Peptides Modified with Triterpenoids and Small Organic Molecules: Synthesis and use in Cosmeceutical - The present invention relates to the Synthesis of Triterpenoid peptides and mechanism of action for Anti ageing and skin care. The present invention is directed towards anti-aging skin care compositions comprising peptides which are made by linking herbal actives to a pentapeptide for enhanced anti ageing activity by regenerating the dermal matrix. In detail, the present invention relates to the Synthesis of Triterpenoid peptides, providing an enhanced and synergistic activity for reducing the consequences of ageing such as appearance of fine expression lines and wrinkles on the skin by cosmetic modes of application. The Triterpenoid peptides of the present invention with its novel dual action mode can be used for skin ageing & collagen insufficiency. Its Triterpenoid group acts by preventing oxidation and excess activity of serine proteases like elastase and collagenase that result in wrinkling of skin. With added peptides which boost the collagen and other matrix protein, Triterpenoid peptides provide a complete protection against pre mature ageing and functions as a best anti ageing ingredient. | 07-24-2014 |
20140249219 | Anti-obesity potential of Calebin A - The present invention discloses the potential of Calebin A in inhibiting adipogenesis and applications thereof in obesity management. The present invention elucidates the potential of Calebin A to favorably modulate biochemical markers associated with obesity. Notable biomodulatory properties of Calebin A include inhibiting leptin production, increasing adiponectin expression and inhibiting local (adipocyte) and systemic inflammation caused by pro-inflammatory cytokines Tumor Necrosis Factor (TNF-α), Interleukin-6 (IL-6) and Interleukin-1 (IL-1β). | 09-04-2014 |
20140303258 | Method of solubilizing insoluble bioactive compounds using triterpene glycosides and compositions thereof - Disclosed are the uses of triterpene glycosides as non-toxic natural solubilizing agents for bioactive compounds and/or metabolites thereof. Triterpene glycosides are also shown to solubilize insoluble natural extracts. Also disclosed are exemplary methods and compositions incorporating the uses of triterpene glycosides as non-toxic natural solubilizing agents. | 10-09-2014 |
Patent application number | Description | Published |
20110054018 | Inotilone derivatives as coherent biological response modifier (cBMR) - Optimal compositions of derivatives of 5-methyl-3(2H)-furanone compounds and phenylpropanoid polyketides related to inotilone, that exert biological response modification in health and disease, and their method of preparation, are disclosed. Methods of treating degenerative conditions stemming from over-expression of inducible nitric oxide synthase (iNOS) using these compositions are also disclosed. | 03-03-2011 |
20110091398 | OLEANOYL PEPTIDE COMPOSITION AND A METHOD OF TREATING SKIN AGING - The present invention relates to a composition containing peptide of SEQ ID No. 1 linked to oleanolic acid and a method of treating skin aging. The composition effectively reduces signs of ageing due to oxidation, collagen insufficiency and excess activity of serine proteases like elastase and collagenase that result in wrinkling of skin, fine expression lines, reduced skin thickness, hyperpigmentation, under eye dark circles, and premature ageing. | 04-21-2011 |
20110218172 | COMPOSITION FOR DOWN-REGULATING PRO-INFLAMMATORY MARKERS - The present invention provides a composition for down-regulating pro-inflammatory markers. The composition comprises boswellic acid fraction and polysaccharide faction obtained from | 09-08-2011 |
20120088841 | COMPOSITION AND A METHOD OF TREATING CNS DISORDERS AND HYPERPIGMENTATION - The present invention relates to a method of treating CNS disorders, particularly Alzheimer's disease. The method comprise step of administering to a subject in need thereof a therapeutically effective amount of hydroxychavicol and/or its derivatives or a composition comprising hydroxychavicol and/or its derivatives optionally along with pharmaceutically acceptable excipients. The invention also relates to use of hydroxychavicol and/or its derivatives for treating hyperpigmentation. | 04-12-2012 |
20120178801 | COMPOSITIONS AND ITS USE IN TREATING OBESITY OR INDUCING WEIGHT LOSS - The present invention provides a composition comprising polyisoprenylated benzophenone derivative and at least one component selected from stilbene derivative and anthocyanins. The composition inhibits adipogenesis and is therefore useful in treating obesity or weight loss. | 07-12-2012 |
20130017605 | ORALLY BIOAVAILABLE STILBENOIDS- COMPOSITIONS AND THERAPEUTIC APPLICATIONS THEREOF - A novel, bioavailable and safe stilbenoid 3,5-dimethoxy-3,4′-dihydroxystilbene represented by SIR#1 with an unexpected enhanced ability to prevent the accumulation of lipids accompanying the terminal differentiation of adipocytes, thereby inhibiting adipogenesis, and nutraceutical and cosmeceutical compositions comprising, dimethoxy-3,4′-dihydroxystilbene useful for anti-obesity and anti-cellulite therapy, are disclosed. Further the enhanced SIRT-1 activation ability of 3,5-dimethoxy-3,4′-dihydroxystilbene represented by STR#1 and 2,3′,5′,6-tetrahydroxy-trans-stilbene represented by STR#II are disclosed. The enhancement of SIRT-1 polypeptide activity of the said compounds is unexpectedly much higher than resveratrol or its natural analog pterostilbene. Sirtuin modulating compositions comprising an orally bioavailable SIRT-1 enhancing compounds (i) 3,5-dimethoxy-3,4′-dihydroxystilbene represented by STR#I and (ii) 2,3′,5′,6-tetrahydroxy-trans-stilbene represented by are also disclosed. An additional embodiment, also discloses the enhanced anti- | 01-17-2013 |